Transpl Infect Dis
-
Publication Venue For
- Maribavir versus investigator assigned therapy: Exploring the exploratory.. e14063. 2023
- Real-world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high-risk donor seropositive/recipient seronegative (D+R-) liver transplant recipients (LTxR).. 25:e14015. 2023
- An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization.. 25:e13951. 2023
- Combined assessment of Epstein-Barr virus viral capsid antigen and Epstein-Barr virus nuclear antigen-1 serology for post-transplant lymphoproliferative disorder risk stratification in adult solid organ transplant recipients.. 24:e13933. 2022
- Gram-negative bacteremia in solid organ transplant recipients: Clinical characteristics and outcomes as compared to immunocompetent non-transplant recipients.. 24:e13969. 2022
- Antimicrobial stewardship in solid organ transplant recipients: Current challenges and proposed metrics.. 24:e13883. 2022
- Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States.. 24:e13866. 2022
- Low risk high reward: What should we worry about with coronavirus disease 2019 positive donors?. 24:e13892. 2022
- Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018.. 24:e13800. 2022
- The pandemic provides a pathway: What we know and what we need to know about using COVID positive donors.. 23:e13727. 2021
- Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers.. 23:e13636. 2021
- Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated.. 23:e13650. 2021
- Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients.. 23:e13687. 2021
- Disseminated Legionella micdadei infection in a liver transplant patient presenting as pulmonary nodules and a laryngeal lesion.. 23:e13563. 2021
- Risks and outcomes of adenovirus disease in pediatric hematopoietic stem cell transplant recipients-Comparison of current antiviral treatment options.. 23:e13505. 2021
- Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee.. 23:e13458. 2021
- Treatment of multidrug-resistant gram-negative bacilli after solid organ transplant: Outcomes and complications.. 23:e13474. 2021
- Kidney transplant recipients infected by COVID-19: Review of the initial published experience.. 22:e13426. 2020
- Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States.. 22:e13283. 2020
- Respiratory pathogens associated with intubated pediatric patients following hematopoietic cell transplant.. 22:e13297. 2020
- Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology.. 21:e13141. 2019
- Pre- and post-transplant bacterial infections in liver transplant recipients.. 21:e13152. 2019
- Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.. 21:e13145. 2019
- The use of genome sequencing to investigate an outbreak of hospital-acquired mucormycosis in transplant patients.. 21:e13163. 2019
- Donor derived HSV hepatitis in a kidney transplant recipient leading to liver fibrosis and portal hypertension.. 21:e13029. 2019
- Genomic characterization of recurrent mold infections in thoracic transplant recipients.. 20:e12935. 2018
- Nocardia infections in the transplanted host.. 20:e12902. 2018
- Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system.. 20:e12910. 2018
- A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.. 20:e12874. 2018
- Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.. 20. 2018
- High clinical suspicion of donor-derived disease leads to timely recognition and early intervention to treat solid organ transplant-transmitted lymphocytic choriomeningitis virus.. 19. 2017
- The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).. 18:921-931. 2016
- Aerosolized ribavirin: the most expensive drug for pneumonia.. 18:634-636. 2016
- Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.. 18:210-215. 2016
- Hepatitis B core antibody-positive donors in cardiac transplantation: a single-center experience.. 16:859-863. 2014
- Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).. 16:213-224. 2014
- Nosocomial infections within the first month of solid organ transplantation.. 16:171-187. 2014
- Pericarditis mediated by respiratory syncytial virus in a hematopoietic stem cell transplant patient.. 15:E152-E156. 2013
- Communication gaps for solid organ transplant-transmitted infections among infectious disease physicians: an Emerging Infections Network survey.. 15:8-13. 2013
- Disseminated Mycobacterium immunogenum infection presenting with septic shock and skin lesions in a renal transplant recipient.. 14:415-421. 2012
- Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae.. 14:229-236. 2012
- A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation.. 14:17-23. 2012
- The use of recombinant human activated protein C (drotrecogin alpha) in solid organ transplant recipients: case series and review of the literature.. 13:592-597. 2011
- Herpes simplex virus hepatitis after renal transplantation.. 10:377-378. 2008